Results 11 to 20 of about 18,705 (234)
Humphry Osmond coined the term ‘psychedelic’ in 1956, conjoining ‘psyche’ for ‘soul’ and ‘delic’ from ‘dêlos’ for ‘to manifest’ or ‘illuminate.’ Soul-illumination is an adjective that describes a psychological state or process. However, Osmond’s intention was to use the adjective to name— not just a state— but a category of drug that can induce the ...
Ostrand AE +9 more
europepmc +4 more sources
Psychedelics are compounds that alter consciousness by acting on serotonin receptors in the brain. The term 'psychedelic', from the Greek for mind manifesting, refers to the drugs' subjective effects and was first proposed by Humphry Osmond in 1956. Other terms have been used to emphasize different aspects of the psychological experiences produced by ...
Benjamin, Kelmendi +3 more
openaire +3 more sources
Case analysis of long-term negative psychological responses to psychedelics
Recent controversies have arisen regarding claims of uncritical positive regard and hype surrounding psychedelic drugs and their therapeutic potential. Criticisms have included that study designs and reporting styles bias positive over negative outcomes.
Rebecka Bremler +4 more
doaj +1 more source
Effects of psilocybin versus escitalopram on rumination and thought suppression in depression
Background Major depressive disorder is often associated with maladaptive coping strategies, including rumination and thought suppression. Aims To assess the comparative effect of the selective serotonin reuptake inhibitor escitalopram, and the ...
Tommaso Barba +8 more
doaj +1 more source
Researchers' Experiences with IRB Oversight of Psychedelic Research. [PDF]
ABSTRACT Previous research raises concern that conservative institutional review board (IRB) approaches regarding stigmatized issues and vulnerable groups could similarly arise as an impediment to research with psychedelic drugs. We interviewed 20 US researchers who had been a principal investigator on at least one research protocol involving ...
Neitzke-Spruill L +5 more
europepmc +2 more sources
Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing
Psychedelic microdosing describes the ingestion of near-threshold perceptible doses of classic psychedelic substances. Anecdotal reports and observational studies suggest that microdosing may promote positive mood and well-being, but recent placebo ...
L. S. Kaertner +9 more
doaj +1 more source
Survey-based studies suggest naturalistic psychedelic use provides mental health benefits similar to those observed in clinical trials. The current study sought to confirm these findings in a large group of psychedelic users and to conduct a novel ...
Charles L. Raison +4 more
doaj +1 more source
In medical trials, ‘blinding’ ensures the equal distribution of expectancy effects between treatment arms in theory; however, blinding often fails in practice.
Balázs Szigeti +3 more
doaj +1 more source
Psychedelics and Personality [PDF]
In the past decade, an increasing number of clinical trials are reporting evidence that psychedelics or serotonergic hallucinogens (such as lysergic acid diethylamide, psilocybin, and ayahuasca/dimethyltryptamine) could be effective in the treatment of mood, anxiety, and substance use disorders.
Marc, Aixalà +3 more
openaire +2 more sources
Psychedelics and Psychedelic-Assisted Psychotherapy
The authors provide an evidenced-based summary of the literature on the clinical application of psychedelic drugs in psychiatric disorders.Searches of PubMed and PsycINFO via Ovid were conducted for articles in English, in peer-reviewed journals, reporting on "psilocybin," "lysergic acid diethylamide," "LSD," "ayahuasca," "3,4 ...
Collin M, Reiff +7 more
openaire +4 more sources

